ferabright®
ferumoxytol injection
Bright for
Brain Tumors
铁基造影剂
The first and only iron-based MRI contrast agent approved by FDA for brain imaging. Revolutionary ferumoxytol injection for visualizing blood-brain barrier disruption in malignant neoplasms.
MRI Compatible
Clinical Environment
Revolutionary Iron-Based Technology
ferabright® delivers superparamagnetic iron oxide nanoparticle enhanced imaging with superior advantages over traditional contrast agents
First Iron-Based Brain MRI Agent
Global breakthrough in brain tumor imaging technology, replacing traditional gadolinium-based agents with innovative iron nanoparticles.
Enhanced Blood-Brain Barrier Visualization
Superior detection of BBB disruption in gliomas, brain metastases, and micro lesions with unprecedented clarity.
Extended Imaging Window
Longer imaging duration enables delayed scanning, flexible protocols, and comprehensive sequence selection.
Safe for Renal Impaired Patients
Alternative solution for patients with kidney dysfunction who cannot receive gadolinium-based agents.
Natural Iron Metabolism
Eliminated through body's natural iron pathways, reducing concerns about long-term heavy metal accumulation.
Superior Contrast Performance
High relaxivity superparamagnetic properties provide exceptional contrast enhancement and diagnostic precision.
See ferabright® In Action
Watch how this revolutionary iron-based MRI contrast agent is transforming brain tumor imaging and patient care
Revolutionary Iron-Based Brain Imaging
Discover how ferabright® is setting new standards in brain MRI contrast enhancement with superior safety and efficacy profiles.
Your Safety Priority
ferabright® represents a paradigm shift in contrast agent safety, offering iron-based imaging solutions with comprehensive safety profiles for diverse patient populations.
Kidney-Safe Formulation
Safe alternative for patients with chronic kidney disease who cannot receive gadolinium-based agents
No Heavy Metal Deposition
Iron-based chemistry eliminates concerns about gadolinium brain deposition
FDA Approved Safety Profile
Rigorous clinical testing confirms safety and efficacy for brain tumor imaging
Exclusive Distribution in Greater China
澳门五洲药物国际贸易有限公司 - Your trusted pharmaceutical partner
Macau Headquarters
澳門五洲藥物國際貿易有限公司
WUZHOU DRUG INTERNATIONAL TRADING LIMITED
澳門電廠巷22號亨達大廈地下AJ座
Travessa da Central Térmica no22 Edifício Hantec r/c "AJ", Macau
Tel: +853 6588 5387
Email: info@droga.cn
Hong Kong Sales
香港医药国际贸易有限公司
ROOM 208，2/F，LUCKY BUILDING
3-5 SAN MA TAU STREET, TO KWA WAN
Hong Kong
Singapore Agent
Singapore BIOPHARMA PTE. LTD.
9 Tampines Grande, Asia Green
#02-00, Singapore 528735
Ready to Learn More About Ferabright™?
Contact our team for detailed product information, clinical data, and ordering details. Experience the future of brain MRI imaging.